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Abstract The efﬁcient establishment of high protein
producing recombinant mammalian cell lines is
facilitated by the use of a stringent selection system.
Here, we describe two methods to create a stringent
selection system based on the Zeocin resistance
marker. First, we cloned increasingly longer stretches
of DNA, encoding a range of 8–131 amino acids
immediately upstream of the Zeocin selection marker
gene. The DNA stretches were separated from the
open reading frame of the selection marker gene by a
stopcodon. The idea behind this was that the transla-
tion machinery will ﬁrst translate the small peptide,
stop and then restart at the AUG of the Zeocin marker.
This process, however, will become less efﬁcient with
increasingly longer stretches of DNA upstream of the
Zeocin marker that has to be translated ﬁrst. This
would result in lower levels of the Zeocin selection
marker protein and thus a higher selection stringency
of the system. Secondly, we performed a genetic
screen to identify PCR induced mutations in the
Zeocin selection protein that functionally impair the
selection marker protein. Both the insertion of
increasingly longer peptides and several Zeocin
selection protein mutants resulted in a decreasing
number of stably transfected colonies that concomi-
tantly displayed higher protein expression levels.
When the Zeocin mutants were combined with very
short small peptides (8–14 amino acids long), this
created a ﬂexible, high stringency selection system.
The system allows the rapid establishment of few, but
high protein producing mammalian cell lines.
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Recombinant gene expression
Introduction
To create stably transfected mammalian cell lines an
efﬁcient selection system is required to (a) kill
untransfected cells and (b) achieve high protein
expression levels. In general, with a more stringent
selection system low-expressing cells will be killed
more efﬁciently, and the expression levels of the
protein of interest will be higher. Also, more stringent
selection systems usually create fewer colonies after
transfection, but these colonies will display higher
protein expression values.
Previously, we described a very high stringency
selection system in which a selection marker was
modiﬁed with startcodons that confer attenuated
translation initiation frequency (Kozak 2001; Van
Blokland et al. 2007). These codons are used for
translation of the selection marker that is placed
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with optimal translation initiation properties. The
modiﬁed startcodon can be a GTG or TTG instead of
an ATG, resulting in selection markers such as GTG
Zeocin (GTG Zeo), TTG Zeocin (TTG Zeo) or TTG
Neomycin (TTG Neo). The selection marker is
translated at a low frequency from the transcribed
bicistronic mRNA due to the attenuated translation
initiation codon. Thus, in order to produce enough
selection marker protein for the cell to survive, high
amounts of bicistronic mRNA levels have to be
expressed. Since the bicistronic mRNA also encom-
passes the gene of interest, which has an optimal
translation initiation codon, concomitantly high lev-
els of the protein of interest will be produced.
One drawback of this selection system is that, in
practice, there are in fact only two suitable modiﬁed
translation initiation codons available, the GTG and
TTGcodons.Ofthesetwo,theuseoftheGTGcodonin
combination with the Zeocin selection marker created
not a very stringent selection system (Van Blokland
etal.2007).Incontrast,theTTGcodonincombination
withtheZeocinmarkerprovidedaselectionstringency
thatoperatesverywellincelllinessuchasCHO-K1or
CHO-DG44, but with other cell lines, the TTG Zeocin
variant proved to be too stringent. To circumvent this
problem we attempted to create a different selection
systemthathasmoreﬂexibilitythanonlyoneavailable
modiﬁedtranslationinitiationcodon.Herewedescribe
a novel selection system that allows a gradual modu-
lation of the selection stringency of the Zeocin marker
and the establishment of a few cell lines that display
high protein expression levels.
Materials and methods
Creation of the small open reading frames
ppLUC 8 and ppLUC 14 were made by annealing the
following complementary primers:
ppLUC8-I; ctagcatgggtcttatgattatgtccggttaag
ppLUC8-II: gatccttaaccggacataatcataagacccatg
ppLUC14-I: ctagcatgggcgaactgtgtgtgagaggtcctatg
attatgtccggttaag
ppLUC14-II:
gatccttaaccggacataatcataggacctctcacacacagttcgcccatg
ppLUC 23, 75, 91 and 131 were made by
amplifying a stretch of DNA from the luciferase
gene (accession number pGL3 Basic E1751, Pro-
mega) by PCR using the following primer
combinations:
pp23-forward: gctagcatggggaaaacgctgggcgttaatc
pp74-forward: aggcgctagcatggccaagaggttccatctg
pp91-forward:aggcgctagcatggaaattgcttctggtggcgctc
pp131 forward: aggcgctagcatggaattatttttgaggtcg
ttgc
luc stop-reverse: aggcactagtttaaccggacataatcataggac
The resulting DNA fragments were cloned into a
NheI site upstream of the d2EGFP reporter gene. For
the cyclin kinase inhibitor p30 Kip1 derived peptides,
the same procedure was applied as for the LUC
peptides using annealing primers for ppKIP8 and 14
and amplifying a stretch of DNA in case longer
peptide by PCR using a cDNA clone as a template
(accession number U49649.1).
Creation of the Error Prone PCR Zeocin mutants
We created mutations in the Zeocin resistance marker
gene by PCR ampliﬁcation of the gene in such a way
that random mutations are introduced. More manga-
nese and magnesium ions in the reaction mix, as well
as an adjusted mix of nucleotides induce random
mutations in the PCR product (Bloom et al. 2005).
50 ng of the pCMV/ZEO plasmid (Invitrogen,
V50120) that harbors the Zeocin gene was ampliﬁed
with 0.75 lM each of the following primers:
Zeo forward: attaggatccaccatggccaagttgaccagtgccg
Zeo reverse: accggaattctcagtcctgctcctcggccacg
The reaction was performed in 7 mM MgCl2,
75 lM MnCl2, 0.2 mM dATP, 0.2 mM dGTP,
0.5 mM dTTP, 0.5 mM dCTP, 19 GOTaq buffer
(Promega) with 5 u GOTaq polymerase (Promega).
Ampliﬁcation was for 10–40 cycles for 1 min at
95 C, 1 min at 50 C, and 1 min at 72 C. The
resulting Zeocin fragments derived from the PCR
reaction were cut with BamH1 and EcoRI, and cloned
behind the EM7 promoter in a pBluescript derived
plasmid, which also harbors the Ampicillin resistance
gene. E.coli (XL10) colonies were selected on LB
agar plates with 100 lg/mL ampicillin. Since the
Ampicillin resistance gene is not affected by the PCR
procedure on the Zeocin resistance gene, equal
numbers of ampicillin-resistant colonies are to be
expected, even if the Zeocin resistance gene is
functionally totally destroyed by mutations.
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were then plated on LB agar plates containing both
100 lg/mL ampicillin and 50 lg/mL Zeocin. The
growth of the recombinants was then compared to the
growth of E.coli XL10 transformed with the wild
type Zeocin gene. This results in a lower ratio of Zeo/
Amp resistant colonies. Colonies showing impaired
growth on Zeocin were then further characterized by
plating them on various Zeocin concentrations and
genotypically indentiﬁed by sequencing (BaseClear,
Leiden, The Netherlands).
Cell culture, transfection, and analysis of clones
CHO-DG44 (Urlaub et al. 1983) cells were grown in
DMEM F12 medium, supplemented with 4.6% fetal
bovine serum (FBS), 2 mM glutamine, 100 U/mL
penicillin,100 lg/mL streptomycin, 100 lM sodium
hypoxanthine, 16 lM thymidine (Invitrogen), and
10 mM MgCl2 at 37 C/5% CO2.
For transfections, 0.4 9 10
6 CHO-DG44 cells
were seeded in 6-well culture plates 24 h prior to
transfection. Cells were transfected with 3 lgo f
plasmid DNA using LipofectamineTM 2000 (Invit-
rogen) as described by the manufacturer. In brief,
LipofectamineTM 2000 was combined with plasmid
DNA at 4 lL of lipofectamine/lg of pDNA. The
mixture was added to the cells, which had grown to
70–90% conﬂuence. After 5 h, the transfection mix-
ture was replaced by fresh medium. The following
day, cells were seeded in serial dilutions into medium
containing Zeocin (Invitrogen) at a concentration of
400 lg/mL. Approximately 12 days after transfec-
tion, individual colonies became visible and these
were isolated and propagated in 24-well plates in
medium containing Zeocin. When grown to *70%
conﬂuence, cells were transferred to 6-well plates.
Cells were continued to grow in 6-well plates for
another 1–2 weeks before FACS analysis was
performed. The d2EGFP expression levels were
determined on an Epics XL Beckman Coulter ﬂow-
cytometer. In case of transient transfections, d2EGFP
expression levels were determined 24 h following
transfection.
RT PCR protocol
Zeocin RNA levels were quantiﬁed in a selected
number of clones, by using qRT-PCR. Individual
clones were grown in 6-well plates from which the
total RNA was extracted using the RNeasy extraction
kit (Qiagen) according to the manufacturer’s proto-
col. Per sample 0.2 lg of RNA was treated with
DNAseI followed by cDNA synthesis using random
hexamer primers (SuperScript III, Invitrogen). The
cDNA was diluted (1:100) followed by a real-time
PCR (40 cycles in a two-step protocol) using the
Cybr-Green Taq mix (Bio-Rad). Primer-pairs with
amplicons of 100–200 bp length were used that were
speciﬁc for coding region of the Zeocin selection
marker and the endogenous b-actin gene, which was
used to relatively quantify the RNA levels per
sample. For each primer pair a minus RT control
sample was included to quantify the background
signal.
Western blot analyses
Immunodetection of the different mutated Zeocin
proteins was performed preparing total cell lysates of
1.6 9 10
6 CHO-DG44 cells, 24 h post-transfection in
100 lL2 9 SDS sample buffer (100 mM dithiothre-
itol, 2% SDS, 50 mM Tris, pH 6.8, 10% glycerol and
0.1% bromophenol blue), at approximately 2 9 10
6–
1 9 10
7 cells/mL. Per sample 10 lL was subjected to
electrophoresis on a 15% SDS–polyacrylamide gel
and transferred to a nitrocellulose membrane by
electroblotting. A 1:3,000 dilution of an anti-Sh ble
(Zeocin resistance protein) rabbit antiserum (Cayla)
was incubated with the membrane followed by a
secondary incubation with a 1:5,000 dilution of goat
anti-rabbit antibody conjugated to alkaline phospha-
tase (Jackson Immuno Research Lab).
Results
Experimental set up
Normally, translation of the wild type Zeocin selec-
tion marker starts with an ATG. We preserved this
conﬁguration, but we placed small open reading
frames (ORFs) of different lengths upstream of this
AUG. Each stretch started with an optimal AUG to
provide a translation initiation codon, and a TAA stop
codon, which was placed upstream of the AUG of the
Zeocin selection marker. The idea underlying these
Zeocin gene conﬁgurations is that translation will be
Cytotechnology (2011) 63:371–384 373
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at the stop codon of the RNA stretches, thus creating
small non-functional peptides. However, since the
peptides are relatively small, the translation machin-
ery is likely to re-initiate translation when it encoun-
ters a second AUG present on the same messenger
RNA; in this conﬁguration at the start of the coding
region for Zeocin (Kozak 2001). This ability of the
translation machinery will diminish however, when
the upstream open reading frames become longer.
Thus, a Zeocin selection marker open reading frame
(ORF) coupled to a small upstream ORF encoding 8
amino acids will be less efﬁciently translated than
when no extra RNA stretch is present (wild type), but
will still be more efﬁciently translated than a Zeocin
selection marker coupled to an upstream ORF
encoding 91 amino acids. As a result, the last
mentioned Zeocin marker (with a peptide of 91
amino acids) will functionally become a more
stringent selection marker than the Zeocin selection
marker preceded by the 8 amino acids long small
peptide, which in turn will be more stringent than the
wild type Zeocin marker. The translation efﬁciency
of the selection marker and thereby the selection
stringency in this conﬁguration depends on the length
of the ORF in front of the Zeocin selection marker.
To test this experimental set up we created a series
of plasmids in which short stretches of DNA were
placed upstream of a reported gene. As reporter gene
we took the d2EGFP gene, which was driven by the
CMV promoter (Fig. 1a). The ORFs were taken
arbitrarily from the coding region of the luciferase
gene (Fig. 1b) or p30 Kip1 gene (Fig. 1c). Different
lengths were taken encoding, respectively peptides of
7, 13, 22, 73, 90 and 131 amino acids. Each ORF
started with an optimal AUG to provide a translation
initiation codon, thus creating peptides of 8, 14, 23,
74, 91 and 131 amino acids in total (as such indicated
in Fig. 1b, c). All ORFs further contained a TAA stop
codon, which was placed upstream of the AUG of the
d2EGFP gene, with 19 nucleotides between the
stopcodon of the luciferase ORF and the AUG of
the d2EGFP gene. Seven different constructs were
thus created, containing no peptide (pp0), or a small
peptide (pp for ‘petit peptide’), 8, 14, 23, 74, 91 or
131 amino acids long (Fig. 1d). These constructs
were transfected to CHO-DG44 cells and 24 h after
transfection cells were analyzed for d2EGFP protein
expression by ﬂowcytometry. The ﬂuorescence signal
derived from d2EGFP (destabilized) is linear with the
amount of available d2EGFP protein in a cell, and is
thus a reliable indicator of the d2EGFP expression
levels in the cell. As is shown in Fig. 1d, placing a
short ORF upstream of the d2EGFP reporter gene had
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Fig. 1 Inﬂuence of the length of an upstream small peptide on
transient expression. a Stretches of DNA of 6 different lengths
were cloned immediately upstream of ATG of the d2EGFP
reporter gene. Each DNA stretch contained a 50 ATG and was
terminated by a TAA stop codon. The CMV promoter drove
expression. Different constructs were thus created, containing
no peptide, or a small peptide (pp for ‘petit peptide’). The
constructs are a control construct, containing no peptide (pp0),
pp8, 14, 23, 74, 91 and 131. Furthermore, a control stretch of
DNA, derived from the luciferase gene, containing no internal
ATGs and no ATG translation initiation codon was placed
upstream from the d2EGFP gene (called pp91 ATG
-).
b Stretches of DNA that were taken from the luciferase gene.
The protein sequence and position of the above indicated
stretches are shown. c Stretches of DNA that were taken from
the p30 Kip1 gene. The protein sequence and position of the
above indicated stretches are shown. d The above described
constructs were transiently transfected and 24 h after transfec-
tion cell were analyzed for d2EGFP protein expression by
ﬂowcytometry. The d2EGFP values with the luciferase (light
bars) and p30 Kip1 (black bars) are shown and their respective
numbers indicate the various small peptides
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123a profound and progressive interfering effect on the
d2EGFP expression levels. Inclusion of an 8 and 14
amino acid long luciferase peptide (Fig. 1b) in the
construct resulted in a decrease of d2EGFP expres-
sion to 80 and 30%, respectively, of the d2EGFP
expression level of the control construct (put at
100%). The d2EGFP expression levels decreased
further when longer peptides were included, down to
\10% of the control d2EGFP expression levels when
a 91 or 131 amino acid peptide was placed upstream
of the d2EGFP gene. With increasingly longer
peptides derived from the p30 Kip1 gene (Fig. 1c)
we also noted lower d2EGFP values, but these were
less outspoken than with the peptides derived from
the luciferase gene (Fig. 1d). Based on this result we
decided to perform the further experiments with the
small peptides derived from the luciferase gene
(Fig. 1b) only.
A basic assumption in these experiments was that
the decline in d2EGFP signal correlates with trans-
lation of the small peptide. In a control experiment
we placed a different DNA stretch upstream of the
d2EGFP gene. This stretch of DNA encoded 91
amino acids, but lacked an optimal AUG at the start
to provide a translation initiation codon, and con-
tained no internal ATGs. When we transfected this
construct, we noted no decrease in d2EGFP expres-
sion levels at all (Fig. 1d). This suggests that this
DNA stretch, that potentially encodes 91 amino acids,
is not translated and simply functions as a 50
untranslated leader. Although this is indirect evi-
dence, this result indicates that the decreases in
d2EGFP values we observe upon incorporation of
increasingly longer upstream located peptides, are
indeed due to translation of these peptides.
Placing increasingly longer peptides upstream
of the Zeocin selection marker results
in a decreased number of colonies
We next placed the increasingly longer luciferase
ORFs immediately upstream of a gene encoding a
selection marker. We did this to test whether this
would create more stringent selection marker, due to
the increasingly diminished protein expression levels
of such selection marker. In this example we chose
the Zeocin selection marker protein. We placed the
described pp8, 14, 23, 74, 91 and 131 DNA stretches
of the luciferase gene immediately upstream of the
Zeocin gene (no reporter genes were included in
these constructs). In order to compare the novel
Zeocin selection stringencies with the STAR-Select
system, we compared the constructs with Zeocin
selection markers that were modiﬁed at the transla-
tion initiation codon, e.g., the ATG, GTG and TTG
translation codons. We previously observed that
inclusion of STAR elements in STAR-Select con-
structs have a positive effect on the number of
induced colonies. We therefore tested all constructs
in the absence and presence of a combination of
STAR 7 and 67 upstream of the expression cassettes
and STAR 7 downstream of the expression cassettes.
This conﬁguration has been reported to provide a
favorable context for highly elevated protein expres-
sion levels in multiple cell lines and with different
promoters (Van Blokland et al. 2007).
The same amount of DNA of all constructs was
transfected to CHO-DG44 cells and selection was
performed with 400 lg/mL Zeocin in the culture
medium. After *2 weeks the number of stably
established colonies was counted. As shown in
Fig. 2, transfection of the STAR-Select constructs
containing the ATG Zeo selection marker created
most stable colonies (*1,750) in the absence of
STAR elements and[2,500 in the presence of STAR
elements. The inclusion of the GTG Zeo and TTG
Zeo selection markers resulted in signiﬁcantly less
stable CHO-DG44 colonies. GTG Zeo induced *150
colonies in the absence and *750 in the presence of
STAR elements (Fig. 2). TTG Zeo induced 6 colo-
nies in the absence and 45 in the presence of STAR
elements (Fig. 2).
In comparison, inclusion of pp8 Zeo in the
construct induced *1,050 colonies in the absence
and [2,000 in the presence of STAR elements
(Fig. 2). With the exception of the pp14 (*500
colonies), the inclusion of longer peptides resulted in
the formation of only a few stable colonies when no
STAR elements were included in the construct.
However, when STAR elements were added to ﬂank
the expression cassette, pp14, 23, 74, 91 and 131 still
gave *2,000, *1,400, *475, *250 and *225
stable colonies, respectively.
Thus, inclusion of progressively longer peptides
resulted in the establishment of a decreasing number
of stably transfected colonies. This indicates that with
increasingly longer peptides the resulting Zeocin
selection marker system becomes more stringent.
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result in signiﬁcantly less colonies than inclusion of
the pp91 peptide. Apparently there is an upper limit
to the length of the peptide in relation to the decrease
in colony numbers.
Placing increasingly longer peptides upstream
of the Zeocin selection marker results in increased
expression levels of a reporter protein
We next tested the effects of increasingly longer
small peptides on protein expression levels. To
include the Zeocin selection marker variants in the
constructs, we placed these downstream of an inter-
nal ribosome entry site (IRES) sequence (Fig. 3).
The d2EGFP gene was cloned upstream of the
IRES sequence. We also compared the constructs
with the ATG/GTG/TTG Zeo-d2EGFP STAR-Select
conﬁgurations. All constructs were ﬂanked with
STAR elements 7 and 67.
The same amount of DNA of all constructs was
transfected to CHO-DG44 cells and selection was
performed with 400 lg/mL Zeocin in the culture
medium. Also with these constructs we noticed a
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Fig. 2 Inﬂuence of the length of an upstream peptide on
colony formation in the absence or presence of STAR
elements. The same pp encoding luciferase stretches as used
in Fig. 1b (pp8, 14, 23, 74, 91 and 131) were placed
immediately upstream of a gene encoding the Zeocin selection
marker. The novel pp-zeocin selection stringencies were
compared with known Zeocin STAR-Select selection markers,
e.g., the ATG/GTG/TTG Zeo conﬁgurations. All constructs
were tested in the presence and absence of ﬂanking STARs 7
and 67 encompassing the human b-actin promoter driven
expression cassettes and STAR 7 downstream of the expression
cassettes. The various constructs are schematically depicted
and the bars indicate the average number from three
experiments of stably transfected Zeocin resistant colonies,
obtained with the various constructs as indicated. The SEM is
indicated with error bars
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Fig. 3 The use of small peptides creates a high stringency
selection system that can be used to achieve high protein
expression levels. a The novel Zeocin selection markers with
the same pp encoding luciferase stretches as used in Fig. 1
(pp8, 14, 23, 74, 91 and 131) were placed behind an internal
ribosome entry site (IRES). The Zeocin genes and IRES were
placed downstream of the d2EGFP reporter gene, to determine
the expression levels after selecting stably transfected clones.
As controls the ATG Zeo gene (or pp0) behind the IRES
sequence was used and for comparison the constructs with the
ATG/GTG/TTG Zeo STAR-Select conﬁguration were
included. The various constructs are schematically depicted
and the mean d2EGFP expression levels in the Zeocin resistant
colonies are indicated (bars). b Real-time RT–PCR analysis of
stably transfected CHO-DG44 clones with TTG Zeocin and
pp0, 23, 74 or 91 ATG Zeocin placed behind the IRES. Total
RNA was extracted from 3 clones per construct. First strand
cDNA was used as a template using Zeocin and endogenous b-
actin speciﬁc primers. The Ct values were normalized per
sample for the expression of b-actin and the fold induction was
calculated relative to the average Ct values in the pp0 ZEO
clones. The numbers (top) indicate the mean d2EGFP
expression levels in the three clones
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123declining number of colonies when increasingly
longer peptides were placed upstream of the Zeocin
selection marker (Fig. 3). It is important to note that
the set up in this experiment is different form the
experiment described in Fig. 2. In Fig. 2, the Zeocin
selection marker was placed immediately down-
stream of the b-actin promoter, whereas in Fig. 3
the Zeocin markers were placed downstream of an
IRES sequence. Translation of the Zeocin marker
downstream of an IRES sequence in a bicistronic
mRNA is expected to be less efﬁcient. The conse-
quently lower Zeocin protein levels are expected to
raise the stringency of the selection system, with
fewer colonies as result. This is exactly what we
observed: the overall number of colonies shown in
Fig. 3 is reduced in comparison with the numbers
shown in Fig. 2.
Next, up to 12 independent colonies were propa-
gated before ﬂow cytometric analysis (EPIXS-XL,
Beckman-Coulter), 3–4 weeks after transfection. In a
single FACS analysis, ﬂuorescence signals from a
sample that contain up to 4,000 cells are analyzed.
One such sample of cells is taken from an indepen-
dent, stably transfected cell colony. Since the signal
will vary amongst the individual cells in the colony,
the mean ﬂuorescence level of the *4,000 cells in
the sample is taken as a measure for the d2EGFP
expression level in the stably transfected cell colony.
As shown in Fig. 3a, incorporation of increasingly
longer peptides upstream of the Zeocin selection
marker, gave signiﬁcantly higher d2EGFP expression
levels, as compared to the control construct with the
ATG Zeo (pp0) marker. The average d2EGFP
expression level in the independent colonies rose
from *100 to *700 with the ATG pp0 Zeo and
pp131 Zeo marker, respectively. However, no further
increase in d2EGFP ﬂuorescence values were
observed with the pp131, in comparison to the pp91
peptide, suggesting there is an upper limit to the
increase of selection stringencies, conveyed with
these peptides. Furthermore, also the colony number
did not decline when the peptide became longer than
91 amino acids (Fig. 3a). This is in agreement with
the data shown in Fig. 2, in the context of a slightly
different experimental set up.
It is also important to note that incorporation of the
TTG Zeo selection marker in this same experiment
resulted in an average d2EGFP expression level of
1,150, which is still higher than the average d2EGFP
values reached with the pp91 and 131 small peptides.
It is possible that selection of increasingly higher
protein expressing pp91 or pp131 clones might be
compromised due to an increasing metabolic load in
high protein expressing cells. However, we believe
that this is not the explanation for the upper limit in
protein expression levels with the pp91 and 131
peptides that we observe. If these expression levels
were too high, also colonies induced by the TTG Zeo
construct, which display higher d2EGFP values,
would have been compromised, and this is not the
case. Also, we did for instance not note a decline in
the growth rate of the highest expressing TTG Zeo
clones. This indicates that high d2EGFP expression
values in these colonies are not yet in such a high
range that they start to negatively inﬂuence selection
of these colonies.
One possibility is that the increased d2EGFP
expression levels are not due to altered mRNA levels
in the different mRNAs, but that inclusion of the DNA
stretches encoding the small peptides inﬂuence the
translation rate of the d2EGFP reporter gene. We
therefore analyzed the mRNA levels by real time PCR
in clones that were induced by the TTG ZEO, pp0, 23,
74 and 91 constructs as shown in Fig. 3b. We found
that Zeocin mRNA levels in the clones induced by the
different constructs increased upon inclusion of a
longer peptide, coinciding with higher d2EGFP
expression values (Fig. 3b). A same trend was found
for colonies induced by constructs containing TTG
Zeo marker proteins (Fig. 3b). This indicates that the
differences we ﬁnd in d2EGFP ﬂuorescence levels are
due to differential mRNA levels.
We also determined whether the distance between
the stopcodon of the small ORF and the AUG of the
d2EGFP gene was of inﬂuence on the expression
levels of d2EGFP. The 19 nucleotides we use in the
constructs described in Figs. 1, 2 and 3 were based on
the length of the PCR primer that contained suitable
restriction sites. We did, however, also vary the
distance between the stopcodon of the small peptide
and the AUG of the d2EGFP gene, up to 200
nucleotides. We found no differences in d2EGFP
values (data not shown) and therefore decided to use
the 19 nucleotides in all further experiments.
To assess the broader applicability of the small
peptides to modulate the stringency of a selection
marker we performed two experiments. We transfec-
ted the constructs described in Fig. 3 to CHO-K1
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were induced by constructs that contained increas-
ingly longer peptides (data not shown) and further
that these colonies displayed higher d2EGFP values
(data not shown). The result was very similar to the
described results with CHO-DG44 cells and shows
that these results were not cell type dependent. We
also included the same range of small peptide
encoding DNA stretches upstream of the Neomycin
resistance gene and transfected these to CHO-DG44
cells. Although the overall number of emerging
colonies was higher with the Neomycin resistance
gene than with the Zeocin resistance gene, we
observed the same trend: inclusion of longer peptides
resulted in fewer colonies, displaying higher d2EGFP
expression levels (data not shown). This result
indicates the potential for a broader applicability of
the use of small peptides to modulate the stringency
of selection markers.
Overall we therefore, conclude that the inclusion of
small DNA stretches that translate to small peptides
upstream of a selection marker can be used to increase
the selection stringency of selection markers.
The creation of Zeocin mutant proteins
with attenuated ability to neutralize Zeocin
Inclusion of subsequently longer ORFs upstream of
the Zeocin selection marker has a limit, both in terms
of colony numbers and protein expression levels. In
comparison (Figs. 2, 3), the TTG Zeocin variant
induces signiﬁcantly fewer colonies and these colo-
nies display higher protein expression levels. In order
to obtain similar colony numbers and protein expres-
sion levels as the TTG Zeocin variant we sought
other ways to increase the selection stringency of the
Zeocin marker, in the context of the small peptide
concept. One way of doing this is impairing protein
function by the introduction of mutations. We created
mutations in the Zeocin resistance marker gene by
PCR amplifying the gene in such a way that random
mutations were introduced. More manganese and
magnesium ions in the PCR reaction mix, as well as
an adjusted mix of nucleotides induce random
mutations in the PCR product of the Zeocin resis-
tance gene (Bloom et al. 2005). The resulting Zeocin
fragments derived from the PCR reaction were cloned
behind the EM7 promoter. The plasmid also har-
boured the Ampicillin resistance gene (driven by its
natural, beta lactamase promoter) and colonies were
selected on 100 lg/mL Ampicillin. Randomly chosen
Ampicillin-resistant recombinants were then plated
on agar plates containing both 100 lg/mL Ampicillin
and 50 lg/mL Zeocin. The growth of the recombi-
nants was compared to the growth of E. coli XL10
transformed with the wild type Zeocin gene. Since
the Ampicillin resistance gene is not affected by the
PCR procedure on the Zeocin resistance gene, equal
numbers of Ampicillin-resistant colonies are to be
expected, even if the Zeocin resistance gene is
functionally totally destroyed by mutations. Thus, a
functional impaired Zeocin gene would result in a
lower ratio of Zeo/Amp resistant colonies. We indeed
found (Fig. 4a) that increasing the number of PCR
cycles resulted in a decreasing number of Zeocin
resistant transformants. Consequently, the ratio of
Ampicillin resistant transformants that were also
Zeocin resistant decreased. However, inclusion of
Zeocin fragments in the construct that had undergone
40 PCR cycles hardly delivered colonies that were
both Ampicillin and Zeocin resistant. Apparently,
resulting Zeocin fragments were not anymore able to
produce a selection protein with enough functionality
to confer Zeocin resistance. We therefore chose to
concentrate on Zeocin mutation screens that resulted
from 15 PCR cycles.
A number of Zeocin marker mutants were plated on
different Zeocin concentrations, ranging from 0 to
100 lg/mL Zeocin, as indicated in Fig. 4b. Note that
all constructs containing a mutated Zeocin marker still
grew efﬁciently on ampicillin alone (top panel). As
control Zeocin marker gene we included the wild type
Zeocinprotein(Fig. 4b).ThenovelZeocinmutantsare
describedasZeocinEPP,whichstandsforErrorProne
PCR.Thesemutantswereinvaryingdegreeaffectedby
increasing Zeocin concentrations. For instance, the
Zeo
EPP66 mutant was less affected by increasing
concentrations of Zeocin than the Zeo
EPP7 mutant
(Fig. 4b). In Fig. 5 the amino acid positions of several
EPPZeocinmutationsareshown.Forinstance,theEPP
66, 7 and 14 mutants harbored 1, 2 and 3 mutations,
respectively, at different amino acid positions.
Error Prone PCR created Zeocin mutants confer
different selection stringencies
Next we tested whether the described Zeocin mutants
could be used as high stringency Zeocin selection
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123markers in mammalian CHO-DG44 cells. The differ-
ent Zeocin EPP mutants were cloned in an expression
cassette, encompassing the human b-actin promoter
that drove the d2EGFP gene, followed by an IRES
sequenceand the Zeocin EPP mutants. STAR 7and 67
elements ﬂanked the expression cassettes, as shown in
Fig. 6.Ascomparison weincludedthreeSTAR-Select
constructs in the same experiment. The ATG/GTG/
TTG Zeo conﬁgurations induced[2,500,[2,000 and
68 colonies, respectively (Fig. 6). Selection was per-
formed with 400 lg/mL Zeocin concentration for all
constructs. The decreasing numbers of formed colo-
nies signify the increasing selection stringencies
conferred by the ATG, GTG and TTG translation
initiation codons. In comparison, the wild type Zeocin
gene placed downstream of the IRES sequence also
resulted in the induction of[2,000 colonies.
The different EPP Zeocin mutants induced varying
colonies under the same selection conditions. The
Zeocin EPP5, 7, 66, 14 and 15 mutants were able to
induce 215, 67, 435, 64 and 113 stably transfected
CHO-DG44 colonies, respectively (Fig. 6). This
result shows that the EPP mutations create Zeocin
resistance marker proteins with different selection
stringencies.
When we analyzed the average d2EGFP ﬂuores-
cencevaluesintherespectiveclones,wefoundvarying
values with the different Zeocin mutants (Fig. 7a). Of
the control, STAR-Select constructs, the TTG Zeo
STAR-Select conﬁguration gave the highest d2EGFP
values (average 1,235). The ATG and GTG STAR-
Select conﬁgurations gave average d2EGFP ﬂuores-
cence values of 93 and 147, respectively (Fig. 7a). In
comparison,theZeocinEPP5,7,66,14and15mutants
induced an average d2EGFP values of 525, 973, 187,
1,016 and 674, respectively (Fig. 7a). This indicates
that the EPP5, 7, 14, and 15 mutations induce a
selection stringency in the Zeocin selection marker
proteinthatliesbetweentheselectionstringencyofthe
GTG and TTG Zeo STAR-Select conﬁguration.
The higher selection stringencies conveyed by the
described EPP Zeocin mutants could be due to
0 Zeo/
100 Amp
5 Zeo
100 Amp
10 Zeo/
100 Amp
50 Zeo/
100 Amp
100 Zeo/
100 Amp
Ratio of ZeoR / AmpR colonies
0
0.25
0.50
0.75
1
Number of PCR cycli
EM7 Zeocin Ampicillin AMPR A 
 B
Fig. 4 The Error Prone PCR (EPP) strategy to create high
stringency Zeocin mutants. a The bars indicate the ratio of
stable Zeocin versus Ampicillin resistant colonies for increas-
ing the number of PCR cycles performed on the Zeocin marker.
b Zeocin EPP marker mutants as indicated plated on different
Zeocin concentrations, ranging from 0 to 100 lg Zeocin/mL, in
combination with 100 lg/mL Ampicillin
b
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123impaired functionality of the mutant marker protein.
Alternatively, these mutants could be less stable than
the wild type Zeocin resistance protein. To address
these possibilities, we analyzed whether the expres-
sion levels of these different Zeocin mutants were
similar to the expression of the wild type Zeocin
gene. We transfected the different EPP Zeo mutants
transiently to CHO-DG44 cells and analyzed the
expression levels of the Zeocin resistance protein by
using a speciﬁc antibody against the Zeocin or Sh ble
protein. As shown in Fig. 7b, we found that mutated
Zeocin proteins had a lower expression level than the
wild type Zeocin resistance protein, except mutant
EPP66. The least stringent EPP66 mutant showed the
highest Zeocin marker protein levels, whereas one of
the most stringent mutants EPP7 was hardly detect-
able. The Zeocin protein levels with EPP5, 14 and 15,
lies between EPP66 and 7. This result indicates that a
decreased stability of the resistance protein is at least
partly responsible for the increased selection strin-
gency conveyed by the mutants.
We conclude that Error Prone PCR can be used to
create mutant Zeocin marker proteins that convey
high selection stringency in mammalian cells. The
error prone PCR strategy appears to be successful to
create Zeocin mutants that display a range of
selection stringencies. However, the gaps between
these stringencies are rather large and resemble the
Fig. 5 Amino acid
substitutions in various
Zeocin mutants with
reduced activity
Number of stable ZeoR colonies
0
50
100
150
200
250
300
350
400
-actin ZeoEPPX STAR 7 STAR 7 STAR67 IRES d2EGFP
-actin STAR 7 STAR 7 STAR67 d2EGFP XTG Zeo
450
>2000 >2000 >2500
β
β
Fig. 6 Colony formation induced by Zeocin EPP mutations.
Zeocin mutants as indicated were cloned in an expression
cassette, encompassing the human b-actin promoter that drove
the d2EGFP gene, followed by an IRES sequence and the
Zeocin EPP mutants. STAR 7 and 67 elements ﬂanked the
expression cassettes. In the same experiment, known Zeocin
STAR-Select selection markers (ATG/GTG/TTG Zeo) were
included for comparison. The various constructs are schemat-
ically depicted and the bars indicate the average number from
3 experiments of stably transfected Zeocin resistant colonies
obtained with the constructs as indicated. The SEM is indicated
with errror bars
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123above-explained differences in selection stringencies
between the GTG and TTG Zeo conﬁgurations. In
order to create more ‘in-between’ selection stringen-
cies, we combined several Zeocin EPP marker
mutants with small peptides.
Small peptides, combined with Error Prone PCR
created Zeocin mutants, modulate the selection
stringencies of these Zeocin mutants
We created the Zeocin mutants harboring small
peptides to more subtly modify the selection strin-
gency of the Zeocin marker than with EPP mutations.
We tested several combinations of small peptides and
EPP Zeocin mutants. In Fig. 8 we show three
combinations: a pp8 small peptide placed upstream
of the ATG of the Zeo
EPP15 and Zeo
EPP5 mutants and
a pp73 peptide upstream of the Zeo
EPP66 mutant.
These new Zeocin conﬁgurations were placed down-
stream of the IRES sequence and d2EGFP gene
(Fig. 8). Introducing the small peptides upstream of
the ATG of the Zeo
EPP15, Zeo
EPP5 and Zeo EPP
66
mutants resulted in a progressive decrease in the
number of stably transfected CHO-DG44 colonies
(Fig. 8). In either case, the number of stably trans-
fected clones decreased by more than 50% when a
small peptide was added to the Zeo mutant (Fig. 8).
We further found that the expression levels of the
d2EGFP protein strongly increased upon the inclu-
sion of the pp8 or 74 small peptide (Fig. 8). The
inclusion of the rather long small peptide (pp74) in
the Zeo
EPP66 containing construct resulted in a
selection stringency that resembled the number of
colonies and d2EGFP expression values that were
induced by the Zeo
EPP15mutant (Fig. 8). However,
the Zeo
EPP15 and Zeo
EPP5 mutants, combined with
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Fig. 7 Inﬂuence of Zeocin mutations on reporter protein
expression levels. a Zeocin mutants as indicated were placed
behind an internal ribosome entry site (IRES). The EPP Zeocin
genes and IRES were placed downstream of the d2EGFP
reporter gene, to determine the expression levels after selecting
stably transfected clones. As controls the wild type Zeocin
gene (Zeo WT) behind the IRES sequence was used and for
comparison the constructs with the ATG/GTG/TTG Zeo
STAR-Select conﬁguration were included. The various con-
structs are schematically depicted and the mean d2GFP
expression levels in the Zeocin resistant colonies are indicated
(bars). b Western blot analysis showing the transient CMV
driven expression of the wild type Zeocin resistance marker
and the Zeocin mutants in CHO-DG44 cells 24 h post-
transfection
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Fig. 8 Inﬂuence of the combination of Zeocin mutations with
the use of small peptides on colony formation. Zeocin mutants
EEP 5 and 15 with or without small peptide pp8 were placed
behind an internal ribosome entry site (IRES). The Zeocin
genes and IRES were placed downstream of the d2EGFP
reporter gene. As control the construct with the TTG Zeo
STAR-Select conﬁguration was included. The constructs are
schematically depicted and the bars indicate the mean d2EGFP
expression levels in the stably transfected Zeocin resistant
colonies
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123pp8 induced a number of colonies that displayed
average d2EGFP ﬂuorescence values in the same
range as those induced by the TTG Zeo STAR-Select
conﬁguration (Fig. 8). Inclusion of a pp14 small
peptide upstream of the Zeo
EPP15 and Zeo
EPP5
mutants resulted in an even further decrease of the
induced number of colonies and in average d2EGFP
values that exceeded values induced by TTG Zeo
(data not shown). The pp8 Zeo
EPP15 conﬁguration
resembled most closely the TTG Zeo conﬁguration,
whereas the pp8 Zeo
EPP5 conﬁguration provided an
intermediate selection stringency between the GTG
Zeo and TTG Zeo conﬁgurations (Fig. 8).
These results indicate that with the inclusion of a
small peptide is indeed possible to modify the
selection stringencies of the EPP Zeocin mutants to
a similar range as the STAR-Select conﬁgurations.
Discussion
Various stringent selection systems for the establish-
ment of stable mammalian cell lines have been
described. The need for high stringency selection
comes from the following consideration. With low
stringency selection systems it often takes a consid-
erable effort to screen vast numbers of transfected
colonies in order to establish a cell line that produces
the protein of interest at acceptable high expression
level. Therefore, quite some efforts have been made
to create high stringency selection systems for
mammalian cell lines. In all these cases, high
selection stringency involves either low expression
levels of the selection marker protein, or in case of
normal expression levels, impaired functionality of
the selection marker protein.
There are multiple ways to achieve a high
selection stringency. For instance, the selection
marker protein, such as the Neomycin resistance
protein has been mutated to become less functional
(Sautter and Enenkel 2005). Weak promoters (Niwa
et al. 1991) and destabilising sequences (Ng et al.
2007) have been employed to induce low expression
levels of the selection marker. To increase the
selection stringency of the system, methotrexate that
inhibits the activity of the dhfr selection marker
protein has been added and as a result the entire locus
encompassing the dhfr gene is ampliﬁed (Kaufman
and Sharp 1982; Alt et al. 1978; Kaufman et al.
1985). These 4 examples have in common what all
stringent selection systems want to achieve. By
lowering the availability and/or functionality of the
selection marker protein a cell has to increase the
transcription of the transfected selection genes in
order to raise the level of functional selection marker
protein. If the cell fails to do that, it will die, due to
the presence of the selection agent/inhibitor in the
culture medium. Underlying all these strategies is the
thought that concomitant with raising the expression
levels of the selection marker genes, also higher
levels of the protein of interest are achieved. How-
ever, when the selection marker and the protein of
interest are not on the same messenger RNA, this is
not automatically the case. Therefore, the best way to
achieve this goal is when the genes are coupled to
each other. For instance, an IRES sequence physi-
cally couples the gene of interest to the selection
marker gene. Raising the expression level of the
selection marker automatically results in an increased
transcription of the bicistronic mRNA as well in the
expression of the gene of interest. Previously, we
took a novel step in raising the selection stringency to
a higher level than with the use of an IRES sequence.
The stringent selection system we described was
based on attenuation of the translation of the selection
marker protein. Although described for the Zeocin
selection marker, that system could in principle be
applied to a variety of selection marker proteins.
However, two major difﬁculties arose. As explained
in the introduction, in practice, only the TTG
translation initiation codon was suitable for use in
the stringent selection system. Whereas the GTG
translation initiation codon provided insufﬁcient
selection stringency, the TTG codon, on the other
hand, created too high selection stringency for cell
lines other than CHO derivatives. A second problem
arose from the fact that in this experimental set up the
selection marker is placed upstream of the gene of
interest. The idea behind this concept was that an
attenuated translation initiation codon would result in
scanning of the mRNA by the translation machinery
until it would meet a bona ﬁde AUG codon. In the
system, this would be the AUG of the gene of
interest. However, to achieve that situation, it had to
be avoided that the translation machinery met an
internal AUG in the selection marker mRNA. In the
presence of internal AUGs, translation would initiate,
resulting in either a fusion protein between part of the
382 Cytotechnology (2011) 63:371–384
123selection marker and the protein of interest, or in
merely a truncated selection marker protein. This
could be circumvented by replacement of all internal
AUGs in the selection marker gene. In some cases
this was easy. Zeocin only possesses one AUG.
However, the hygromycin selection marker already
contains 24 AUGs, of which 8 are in frame, making it
virtually impossible to replace them all.
Here, we describe two ways to modify the Zeocin
selection marker to create a stringent selection system
for mammalian cell lines. First, by merely placing a
small ORF upstream of the gene of interest, separated
by a stop codon, we circumvent the need to replace
internalAUGsin the selection gene. Second, the range
in length of the potential peptides creates much more
ﬂexibilitythantheuseoftheTTGtranslationinitiation
codon only. However, even the use of a peptide with
substantial length, proved to be insufﬁcient to create
similarselectionstringencyastheTTGZeocinmarker.
Thiswascompensatedthoughbyintroducingone(orat
most 3) mutations in the Zeocin selection marker
protein that impair the function of the Zeocin marker
protein. By combining these two approaches we
created a versatile selection system that allows the
establishmentoffewmammaliancelllinesthatdisplay
high protein expression levels. Importantly, we can
create selection stringencies that are intermediate in
relation to the respectively high TTG Zeocin and low
GTG Zeocin selection stringencies.
Anotheraspectthatneedstobediscussediswhether
the small peptides are bioactive and require puriﬁca-
tion when applied to enhance the expression of
therapeutic proteins in an industrial setting. We
randomly chose the sequence from the luciferase gene
andhavenoindicationthattheresultingsmallpeptides
would have any function at all. Furthermore, with no
secretion signal present, it appears unlikely that the
peptides will be secreted at all. However, since we can
notexcludethepossibilitycompletely,weprefertouse
the shortest peptides possible, pp8 and 14. Finally,
even in case the small peptides would be released into
theculturemedium,thesepeptidesaresosmallthatitis
unlikely that they would co-purify with the usually
very large commercial therapeutic proteins.
The molecular mechanism underlying the action of
the upstream placed short ORF on the regulation of
the Zeocin selection marker protein is not entirely
clear. The working hypothesis, on which basis we
designed the experiments, was that it involves
initiation of translation at the small peptides and re-
initiation of translation at the AUG of the gene of
interest by ribosomes that have resumed scanning
despite the translation termination signal of the initial
small peptide. We can not prove this assumption
directly. But in a control experiment we showed that
when no ATG translation initiation codon was
present in the DNA stretch potentially encoding the
small peptide and with further no internal ATGs
present, no decreases in d2EGFP levels were
observed (Fig. 1d). This result suggests that the
observed actions of the small peptides on colony
numbers and d2EGFP values is indeed related or due
to the translation of the small peptides. This is not so
far fetched, since there is precedence for such a
scenario in nature. The HER-2 receptor contains a
short upstream ORF in the HER-2 mRNA which
represses the downstream translation of the HER-2
protein in a variety of cell types (Child et al. 1999). It
appears that this inhibitory mechanism is used as a
control mechanism for the expression levels of this
oncoprotein. Results presented here and other studies
in mammalian systems show that the efﬁciency of
re-initiation is reduced as the length of the ORFs is
increased (Kozak 2001). Given this fact and the result
we show in this paper, it is therefore possible to
extend the use of small peptides, other than in
selection systems. When for instance biologically
active proteins need to be expressed at an attenuated
level, modifying the translation efﬁciency of the
protein can be achieved by placing an ORF upstream
of the gene of interest. This may therefore provide a
simple but effective tool to modulate the expression
levels of any protein of interest, not only for
modulating the expression of a selection marker but
also to modulate multi-subunit proteins and multi-
gene engineering.
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